On March 2, 2021 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") reported that management will participate in the H.C. Wainwright (HCW) Global Life Sciences Conference, which is being held digitally March 9-10, 2021 (Press release, Actinium Pharmaceuticals, MAR 2, 2021, View Source [SID1234575948]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Members of Actinium’s executive team will be available for one-on-one meetings with conference attendees. Those interested in scheduling a meeting may do so contacting their representative at HCW or the Company at [email protected]. The Company’s investor presentation can be accessed on the investor relations section of its website: View Source